- Home
- CCBG vs PCRX Comparison
CCBG vs PCRX Comparison
Compare CCBG & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCBG
- PCRX
- Stock Information
- Founded
- CCBG 1895
- PCRX 2006
- Country
- CCBG United States
- PCRX United States
- Employees
- CCBG N/A
- PCRX N/A
- Industry
- CCBG Major Banks
- PCRX Biotechnology: Pharmaceutical Preparations
- Sector
- CCBG Finance
- PCRX Health Care
- Exchange
- CCBG Nasdaq
- PCRX Nasdaq
- Market Cap
- CCBG 625.1M
- PCRX 1.2B
- IPO Year
- CCBG N/A
- PCRX 2011
- Fundamental
- Price
- CCBG $37.72
- PCRX $26.59
- Analyst Decision
- CCBG Buy
- PCRX Buy
- Analyst Count
- CCBG 2
- PCRX 10
- Target Price
- CCBG $39.00
- PCRX $29.30
- AVG Volume (30 Days)
- CCBG 26.6K
- PCRX 892.8K
- Earning Date
- CCBG 01-28-2025
- PCRX 02-27-2025
- Dividend Yield
- CCBG 2.47%
- PCRX N/A
- EPS Growth
- CCBG 1.63
- PCRX N/A
- EPS
- CCBG 3.12
- PCRX N/A
- Revenue
- CCBG $230,883,000.00
- PCRX $694,957,000.00
- Revenue This Year
- CCBG N/A
- PCRX $5.14
- Revenue Next Year
- CCBG $3.97
- PCRX $2.44
- P/E Ratio
- CCBG $11.94
- PCRX N/A
- Revenue Growth
- CCBG 4.53
- PCRX 4.40
- 52 Week Low
- CCBG $25.45
- PCRX $11.16
- 52 Week High
- CCBG $40.86
- PCRX $31.67
- Technical
- Relative Strength Index (RSI)
- CCBG 58.74
- PCRX 77.75
- Support Level
- CCBG $35.44
- PCRX $25.06
- Resistance Level
- CCBG $37.91
- PCRX $27.10
- Average True Range (ATR)
- CCBG 1.08
- PCRX 1.45
- MACD
- CCBG 0.25
- PCRX 0.28
- Stochastic Oscillator
- CCBG 92.10
- PCRX 86.23
About CCBG Capital City Bank Group
Capital City Bank Group Inc is a United States-based group engaged in Banking services, Trust and asset management services, and Brokerage services. The company offers retail and commercial banking business in the form of traditional deposit and credit services, asset management, trust, mortgage banking, merchant services, bank cards, data processing, and securities brokerage services among others through its banking offices in Florida, Georgia, and Alabama.
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.